ライフサイエンスコーパス: melanocyte-stimulating hormone

1 ned with a selective MC3-R agonist (gamma(2)-melanocyte-stimulating hormone).

2 ormone = adrenocorticotropic hormone > gamma-melanocyte-stimulating hormone).

3 asopressin, agouti-related protein and alpha-melanocyte stimulating hormone.

4 mentation does not appear to be regulated by melanocyte stimulating hormone.

5 table levels of adrenocorticotropin or alpha-melanocyte-stimulating hormone.

6 ed how these responses are affected by alpha-melanocyte-stimulating hormone.

7 ction but this response was reduced by alpha-melanocyte-stimulating hormone.

8 e levels were increased in response to alpha-melanocyte-stimulating hormone.

9 mulation of tyrosinase gene transcription by melanocyte-stimulating hormone.

10 on stimulation with its natural ligand alpha-melanocyte-stimulating hormone.

11 d the positive effects of [Nle, D-Phe]-alpha-melanocyte-stimulating hormone.

12 ucagon and proopiomelanocortin-derived alpha-melanocyte-stimulating hormone.

13 We report that alpha-melanocyte-stimulating hormone (10-9 M) was effective in

14 h a selective MC3R agonist ([D-Trp(8)]-gamma-melanocyte-stimulating hormone; 10 microg i.v.) produced

15 des alpha-melanocyte-stimulating hormone and melanocyte-stimulating hormone 11-13 (KP-D-V) on the inv

16 nt in the aqueous humor (10-9 M), as well as melanocyte-stimulating hormone 11-13 (KP-D-V) reduced th

17 (188)Re-(Arg(11))[Cys(3,4,10),d-Phe(7)]alpha-melanocyte-stimulating hormone(3-13) (CCMSH) in the B16/

18 rahydrobiopterin resulting in a stable alpha-melanocyte stimulating hormone/6(R)-L-erythro 5,6,7,8 te

19 cid, and niacinamide) and stimulators (alpha-melanocyte-stimulating hormone, 8-methoxypsoralen, and 3

20 bitor of rac1 abrogated the ability of alpha-melanocyte stimulating hormone, a peptide hormone known

21 One such factor is alpha-melanocyte-stimulating hormone, a potent anti-inflammato

22 f the melanotropin peptides alpha-MSH (alpha-melanocyte-stimulating hormone, Ac-Ser-Tyr-Met-Glu- His-

23 his study provides further evidence of alpha-melanocyte stimulating hormone acting to "protect" melan

24 similar in these two species homologs (alpha-melanocyte-stimulating hormone = adrenocorticotropic hor

25 For this purpose antibodies against alpha-melanocyte stimulating hormone, adrenocorticotropin, pro

26 When treated with a stable alpha-melanocyte-stimulating hormone agonist, mutant mice lost

27 eceptor its and adrenocorticotropic hormone, melanocyte stimulating hormone, agouti protein ligands (

28 alpha-Melanocyte stimulating hormone (alpha-MSH) analogs, cycl

29 ts of two melanocortin system ligands, alpha melanocyte stimulating hormone (alpha-MSH) and agouti-re

30 The regulated release of anorexigenic alpha-melanocyte stimulating hormone (alpha-MSH) and orexigeni

31 The peptides alpha-melanocyte stimulating hormone (alpha-MSH) and oxytocin,

32 ic hormone (ACTH), beta-endorphin, and alpha-melanocyte stimulating hormone (alpha-MSH) are synthesiz

33 n the ARC, IRS-2 was co-localized with alpha melanocyte stimulating hormone (alpha-MSH) as well as ne

34 orms act as competitive antagonists of alpha-melanocyte stimulating hormone (alpha-MSH) at melanocort

35 ne whether the neuroprotective peptide alpha-melanocyte stimulating hormone (alpha-MSH) attenuates GA

36 Alpha-melanocyte stimulating hormone (alpha-MSH) has pigmentar

37 ulated transcript (CART) coexists with alpha-melanocyte stimulating hormone (alpha-MSH) in the arcuat

38 leus (ARC), and on opioid peptides and alpha-melanocyte stimulating hormone (alpha-MSH) in the parave

39 alpha-Melanocyte stimulating hormone (alpha-MSH) is a neuropep

40 The neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) is an importa

41 lanocortin (POMC)-derived neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) is known to m

42 Alpha-melanocyte stimulating hormone (alpha-MSH) is one of the

43 compared with four other radiolabeled alpha-melanocyte stimulating hormone (alpha-MSH) peptide analo

44 sp-conjugated and X-Ala-Asp-conjugated alpha-melanocyte stimulating hormone (alpha-MSH) peptides.

45 w (99m)Tc-labeled Arg-X-Asp-conjugated alpha-melanocyte stimulating hormone (alpha-MSH) peptides.

46 a prevention based on using analogs of alpha-melanocyte stimulating hormone (alpha-MSH) that function

47 The pro-opiomelanocortin product alpha-melanocyte stimulating hormone (alpha-MSH), an MC3/4-R a

48 The concentration of PRL, alpha-melanocyte stimulating hormone (alpha-MSH), and luteiniz

49 age chemoattractant protein-1 (MCP-1), alpha-melanocyte stimulating hormone (alpha-MSH), and peroxiso

50 ReCCMSH(Arg(11)), a cyclic analogue of alpha-melanocyte stimulating hormone (alpha-MSH), exhibited hi

51 tor (CRF) might be mediated via MC4-R. alpha-Melanocyte stimulating hormone (alpha-MSH), the MC4-R ag

52 ing the production of the MC4R ligand, alpha-melanocyte stimulating hormone (alpha-MSH), to regulate

53 C4-R agonists, melanotan-II (MT-II) or alpha-melanocyte stimulating hormone (alpha-MSH), were unilate

54 ARC(POMC) neuron-derived MC4R agonist, alpha-melanocyte stimulating hormone (alpha-MSH).

55 s are stimulated by the native ligand, alpha-melanocyte stimulating hormone (alpha-MSH).

56 stimulated by the melanocortin agonist alpha-melanocyte stimulating hormone (alpha-MSH).

57 ls was blocked by co-administration of alpha-melanocyte stimulating hormone (alpha-MSH, 20 ng), a hor

58 tivity of leptin, the leptin receptor, alpha-melanocyte stimulating hormones (alpha-MSH) and the mela

59 er the functional IL-1beta antagonist, alpha-melanocyte-stimulating hormone (alpha-MSH(1-13)), would

60 ibution, and clearance kinetics of the alpha-melanocyte-stimulating hormone (alpha-MSH) analog 1,4,7,

61 Radiohalogenated alpha-melanocyte-stimulating hormone (alpha-MSH) analogs were

62 eport in vitro and in vivo data of new alpha-melanocyte-stimulating hormone (alpha-MSH) analogues whi

63 NPY) and anorexigenic peptides such as alpha-melanocyte-stimulating hormone (alpha-MSH) and anorexige

64 n, resulting in selective increases of alpha-melanocyte-stimulating hormone (alpha-Msh) and carboxy-c

65 ein-coupled receptor (GPCR) that binds alpha-melanocyte-stimulating hormone (alpha-MSH) and has a cen

66 The neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) and its C-ter

67 he melanocortin system, which includes alpha-melanocyte-stimulating hormone (alpha-MSH) and its endog

68 ese proteins antagonize the effects of alpha-melanocyte-stimulating hormone (alpha-MSH) and other mel

69 ng effects of the anorexigenic agonist alpha-melanocyte-stimulating hormone (alpha-MSH) and the orexi

70 MC4R responds to an agonist, alpha-melanocyte-stimulating hormone (alpha-MSH) and to an ant

71 We have previously shown that alpha-melanocyte-stimulating hormone (alpha-MSH) can oppose tu

72 ntake and PK2 increased the release of alpha-melanocyte-stimulating hormone (alpha-MSH) from ex vivo

73 recordings revealed that both NPY and alpha-melanocyte-stimulating hormone (alpha-MSH) inhibit and s

74 alpha-Melanocyte-stimulating hormone (alpha-MSH) is a potent a

75 Alpha-melanocyte-stimulating hormone (alpha-MSH) is a tridecap

76 Alpha-melanocyte-stimulating hormone (alpha-MSH) is an antiinf

77 the appetite-suppressing neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) is reduced, y

78 TH) of pars distalis corticotropes and alpha-melanocyte-stimulating hormone (alpha-MSH) of pars inter

79 s study aimed at revealing the role of alpha-melanocyte-stimulating hormone (alpha-MSH) on basophil f

80 We report that melanocyte-stimulating hormone (alpha-MSH) or ACTH induc

81 melanocortin receptor agonists such as alpha-melanocyte-stimulating hormone (alpha-MSH) or antagonist

82 phage that displayed up to 5 copies of alpha-melanocyte-stimulating hormone (alpha-MSH) peptide analo

83 he radiolabeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone (alpha-MSH) peptide on it

84 e whether (99m)Tc- and (111)In-labeled alpha-melanocyte-stimulating hormone (alpha-MSH) peptides coul

85 ) neurons and the POMC-derived peptide alpha-melanocyte-stimulating hormone (alpha-MSH) promote satie

86 The alpha-melanocyte-stimulating hormone (alpha-MSH) receptor (mel

87 type 1 receptor (MC1R), also known as alpha-melanocyte-stimulating hormone (alpha-MSH) receptor, is

88 ion (suntanning) requires induction of alpha-melanocyte-stimulating hormone (alpha-MSH) secretion by

89 Activation of MC1R in melanocytes by alpha-melanocyte-stimulating hormone (alpha-MSH) stimulates cA

90 The pituitary peptide alpha-melanocyte-stimulating hormone (alpha-MSH) stimulates me

91 Reduction in the activity of the alpha-melanocyte-stimulating hormone (alpha-MSH) system causes

92 prolylcarboxypeptidase (PRCP) degrades alpha-melanocyte-stimulating hormone (alpha-MSH) to an inactiv

93 t color by antagonizing the binding of alpha-melanocyte-stimulating hormone (alpha-MSH) to the alpha-

94 us of the hypothalamus (PVN), to block alpha-melanocyte-stimulating hormone (alpha-MSH) type 3 and 4

95 1R, inhibiting the alpha-melanocortin (alpha-melanocyte-stimulating hormone (alpha-MSH))-induced incr

96 elanocortin 4 (MC-4) receptors such as alpha-melanocyte-stimulating hormone (alpha-MSH), a product of

97 in the regulation of feeding by using alpha-melanocyte-stimulating hormone (alpha-MSH), an endogenou

98 -tetraacetic acid), a cyclic analog of alpha-melanocyte-stimulating hormone (alpha-MSH), has the pote

99 nd regulating release of products like alpha-melanocyte-stimulating hormone (alpha-MSH), neuropeptide

100 re potent appetite stimulants, whereas alpha-melanocyte-stimulating hormone (alpha-MSH), neurotensin,

101 ither a melanocortin receptor agonist, alpha-melanocyte-stimulating hormone (alpha-MSH), or antagonis

102 (NDP-MSH), a highly potent analogue of alpha-melanocyte-stimulating hormone (alpha-MSH), possesses na

103 designed to examine the evidence that alpha-melanocyte-stimulating hormone (alpha-MSH), which is tho

104 group of Lys(10) of the cyclic lactam alpha-melanocyte-stimulating hormone (alpha-MSH)-derived Pro(6

105 both direct and indirect regulation by alpha melanocyte-stimulating hormone (alpha-MSH)-synthesizing

106 roach, we produced biologically active alpha-melanocyte-stimulating hormone (alpha-MSH).

107 ty of the receptor to bind its ligand, alpha-melanocyte-stimulating hormone (alpha-MSH).

108 irculating and lesional skin levels of alpha-melanocyte-stimulating hormone (alpha-MSH).

109 ce or absence of stimulation by the agonist, melanocyte-stimulating hormone (alpha-MSH).

110 ting mPOMC was converted to des-acetyl alpha-melanocyte-stimulating hormone (alpha-MSH).

111 The anorexigenic neuromodulator alpha-melanocyte-stimulating hormone (alpha-MSH; referred to h

112 ocked by 2 different IL-1 antagonists, alpha melanocyte stimulating hormone (alphaMSH) and interleuki

113 Physiologically activated by alpha-melanocyte stimulating hormone (alphaMSH), MC1R function

114 resembling mice with reduced action of alpha melanocyte stimulating hormone (alphaMSH).

115 melanoma cells synthesize and release alpha-melanocyte stimulating hormone (alphaMSH, the ligand for

116 havior of these cells is influenced by alpha-melanocyte-stimulating hormone (alphaMSH) and melanin-co

117 The POMC-derived peptide alpha-melanocyte-stimulating hormone (alphaMSH) is a melanocor

118 erestingly, hypothalamic Pomc mRNA and alpha-melanocyte-stimulating hormone (alphaMSH) peptide levels

119 alpha-Melanocyte-stimulating hormone also increased the levels

120 the rise in cAMP levels in response to alpha-melanocyte-stimulating hormone, an MC4R agonist, by bloc

121 ce with DIO to treatment with MTII, an alpha-melanocyte-stimulating hormone analog.

122 ions did not affect the ability of the alpha-melanocyte stimulating hormone analogue [Nle4,D-Phe7] me

123 valuated the safety and efficacy of an alpha-melanocyte-stimulating hormone analogue, afamelanotide,

124 The presence of alpha-melanocyte stimulating hormone and adrenocorticotropin i

125 dendrite formation in B16F1 cells, and alpha-melanocyte stimulating hormone and ultraviolet light sti

126 ac1 mediates the well-known ability of alpha-melanocyte stimulating hormone and ultraviolet light to

127 We used known melanogenic stimulators (alpha-melanocyte-stimulating hormone and 3,4-dihydroxyphenylal

128 lanocortin peptides alpha-, beta-, and gamma-melanocyte-stimulating hormone and ACTH are full agonist

129 alpha-Melanocyte-stimulating hormone and adrenocorticotropic h

130 e proopiomelanocortin-derived peptides alpha-melanocyte-stimulating hormone and beta-endorphin, the g

131 enic neuropeptides pro-opiomelanocortinalpha-melanocyte-stimulating hormone and cocaine-amphetamine-r

132 and anorexigenic (pro-opiomelanocortinalpha-melanocyte-stimulating hormone and cocaine-amphetamine-r

133 Both central alpha-melanocyte-stimulating hormone and corticotropin-releasi

134 of the proopiomelanocortin-derived peptides melanocyte-stimulating hormone and corticotropin.

135 ontraction in melanocytes, mediated by alpha-melanocyte-stimulating hormone and melanin-concentrating

136 and of the anti-inflammatory peptides alpha-melanocyte-stimulating hormone and melanocyte-stimulatin

137 -derived macrophages, we observed that alpha-melanocyte-stimulating hormone and selective MC1-R agoni

138 wn that a cell-permeable peptide, a hormone (melanocyte stimulating hormone), and a blood-clotting ag

139 tra of the model peptides (bradykinin, alpha-melanocyte stimulating hormone, and melittin) change sig

140 omelanocortin (POMC)-derived peptides, alpha-melanocyte-stimulating hormone, and adrenocorticotropic

141 rphin A-17, a decrease in the level of alpha-melanocyte-stimulating hormone, and an alteration in the

142 encodes both the anorexigenic peptide alpha-melanocyte-stimulating hormone, and the opioid peptide b

143 including arbutin, hydroquinone, kojic acid, melanocyte-stimulating hormone, and thymidine dimers) as

144 adrenocorticotropin, alpha-, beta- and gamma-melanocyte stimulating hormone; and the endogenous opioi

145 to investigate the mechanism by which alpha-melanocyte-stimulating hormone antagonizes proinflammato

146 and that the anti-invasive actions of alpha-melanocyte stimulating hormone are consistent with its w

147 hormone, beta-lipotropic hormone, and alpha-melanocyte-stimulating hormone are also derived.

148 stochastic carcinogenesis and identify alpha-melanocyte-stimulating hormone as a potential attenuatin

149 Additionally, our results identify alpha-melanocyte-stimulating hormone as a potential mediator o

150 s through the blockade of signaling by alpha-melanocyte-stimulating hormone at central nervous system

151 Full-length alpha-melanocyte-stimulating hormone, at concentrations presen

152 Notably, the density of anorexigenic alpha-melanocyte-stimulating hormone axons was reduced in adul

153 s of novel, disulfide-constrained human beta-melanocyte stimulating hormone (beta-MSH)-derived peptid

154 rupts the dibasic cleavage site between beta melanocyte-stimulating hormone (beta-MSH) and beta-endor

155 Here, we show that the peptide beta-melanocyte-stimulating hormone (beta-MSH) is cleaved by

156 ptides include adrenocorticotrophic hormone, melanocyte stimulating hormone, beta-lipotrophin, and th

157 e precursor for adrenocorticotropic hormone, melanocyte-stimulating hormones, beta-lipotropic hormone

158 prevented the inhibitory actions of gamma(2)-melanocyte stimulating hormone both in vitro and in vivo

159 by the more selective MC3-R agonist gamma(2)-melanocyte stimulating hormone but not by the selective

160 n S-91 mouse melanoma cells respond to alpha-melanocyte-stimulating hormone) by demonstrating a marke

161 Recently, it has been shown that alpha-melanocyte stimulating hormone can directly activate tyr

162 ear run-off transcription assays showed that melanocyte-stimulating hormone caused a slow increase in

163 mers with different molecular sizes, [d-Trp]-melanocyte-stimulating hormone, [d-Ala]-deltorphin, [d-P

164 At concentrations in excess of 10-9 M alpha-melanocyte-stimulating hormone decreased nitric oxide pr

165 cell surface, but it does not restore alpha-melanocyte-stimulating hormone-dependent cAMP signaling.

166 Tc(CO)3-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone derivative, betaAlaNleCyc

167 hat inhibits the binding and action of alpha-melanocyte-stimulating hormone derived from proopiomelan

168 ow report that treatment of melanocytes with melanocyte-stimulating hormone down-regulates expression

169 melanoma cells were exposed continuously to melanocyte-stimulating hormone for 6 d, a large but tran

170 alpha-melanocyte-stimulating hormone from arcuate POMC neurons

171 The gamma-melanocyte-stimulating hormone (gamma-MSH) is a natriure

172 rly to the previously described cyclic gamma-melanocyte-stimulating hormone (gamma-MSH)-derived hMC3R

173 at each position of the short peptide gamma-melanocyte-stimulating hormone (gamma-MSH).

174 gamma-MSH (gamma-melanocyte-stimulating hormone, H-Tyr-Val-Met-Gly-His-Ph

175 These data show that alpha-melanocyte-stimulating hormone has a pronounced effect o

176 alpha-Melanocyte-stimulating hormone, however, decreased induc

177 minase-containing neurons) but not others (a-melanocyte-stimulating hormone), indicating specificity

178 te was unaffected by treatment of cells with melanocyte-stimulating hormone, indicating that the horm

179 Melanocyte-stimulating hormone-induced expression of MIT

180 ment with cycloheximide had no effect on the melanocyte-stimulating hormone-induced increase in tyros

181 In cultured hypothalamic neurons, melanocyte stimulating hormone induces an MC4R-dependent

182 opiomelanocortin (POMC) that is processed to melanocyte-stimulating hormone, inducing tanning.

183 (dynorphin A-17, beta-endorphin, and alpha- melanocyte-stimulating hormone) involved in the control

184 oduction by melanocytes in response to alpha-melanocyte-stimulating hormone is associated with such a

185 Alpha-melanocyte-stimulating hormone is produced by several di

186 Afamelanotide, an analogue of alpha-melanocyte-stimulating hormone, is known to induce tanni

187 n of the fibroblast growth factor (FGFR) and melanocyte stimulating hormone (MC1R) receptors stimulat

188 grin expression and ask to what extent alpha-melanocyte stimulating hormone might protect cells from

189 two intercellular signaling molecules, alpha-melanocyte stimulating hormone (MSH) and agouti signal p

190 uces activation of regulatory T cells, alpha-melanocyte stimulating hormone (MSH) and transforming gr

191 uggested a critical role for the MC1R ligand melanocyte stimulating hormone (MSH) in this response, a

192 ignaling either by the agonistic MC1R ligand melanocyte stimulating hormone (MSH) or by pharmacologic

193 Melanocyte stimulating hormone (MSH) plays an important

194 , from the absence of induction by leptin of melanocyte stimulating hormone (MSH) secretion in the hy

195 gmentation in mammals is stimulated by alpha-melanocyte stimulating hormone (MSH), which binds to the

196 ropic hormone, and alpha-, beta-, and gamma- melanocyte stimulating hormone (MSH).

197 nocortin (MC) receptor agonist DTrp(8)-gamma-melanocyte stimulating hormone (MSH; DTrp).

198 s agonists such as alpha-, beta-, and gamma2-melanocyte stimulating hormones (MSH) and adrenocorticot

199 genous agonists [alpha-, beta-, and gamma(2)-melanocyte stimulating hormones (MSH) and adrenocorticot

200 ptor agonists including alpha-, beta-, gamma-melanocyte stimulating hormones (MSH) and adrenocorticot

201 he intermediate lobe melanotropes, producing melanocyte-stimulating hormone (MSH alpha), have remaine

202 two intercellular signaling molecules, alpha-melanocyte-stimulating hormone (MSH) and agouti signal p

203 r MMS increases the response of S91 cells to melanocyte-stimulating hormone (MSH) and increases the b

204 the selective MC3R agonist [d-Trp(8)]-gamma-melanocyte-stimulating hormone (MSH) and of the recessiv

205 may mediate the hypophagic effects of alpha-melanocyte-stimulating hormone (MSH) in the rat.

206 mes in melanocytes, whereas treatment with a-melanocyte-stimulating hormone (MSH) induced exocytosis

207 zed rats, unilateral microinjection of alpha-melanocyte-stimulating hormone (MSH) into the medullary

208 Alpha-Melanocyte-stimulating hormone (MSH) is a potent anti-in

209 Melanocyte-stimulating hormone (MSH) peptides processed

210 Melanocyte-stimulating hormone (MSH) plays a crucial rol

211 Melanocyte-stimulating hormone (MSH) promotes transcript

212 scopic visualization and characterization of melanocyte-stimulating hormone (MSH) receptors of melano

213 Melanocyte-stimulating hormone (MSH) reduces UV-induced

214 alpha-Melanocyte-stimulating hormone (MSH) utilizes cAMP to tr

215 alpha-Melanocyte-stimulating hormone (MSH), a stimulus which i

216 e and functionality of ACTH, alpha- and beta-melanocyte-stimulating hormone (MSH), and beta-endorphin

217 ion throughout the cytoplasm is triggered by melanocyte-stimulating hormone (MSH), with both of these

218 melatonin, whereas dispersion is induced by melanocyte-stimulating hormone (MSH).

219 omplete loss of both [Nle(4)-d-Phe(7)]-alpha-melanocyte stimulating hormone (NDP-MSH) binding and NDP

220 activity studies of [Nle(4), D-Phe(7)]-alpha-melanocyte stimulating hormone (NDP-MSH) identified D-Ph

221 uti-related protein (AGRP)/[Nle4,DPhe7]alpha-melanocyte stimulating hormone (NDP-MSH) ligands is repo

222 rotective effect of [Nle(4), D-Phe(7)]-alpha-melanocyte stimulating hormone (NDP-MSH), a potent non-s

223 [Nle(4),d-Phe(7)]-alpha-melanocyte-stimulating hormone (NDP-alpha-MSH) labeled w

224 g assays for agonist, [Nle(4)-d-Phe(7)]alpha-melanocyte-stimulating hormone (NDP-alpha-MSH) or forsko

225 human MC4R activation by [Nle4, d-Phe7]alpha-melanocyte-stimulating hormone (NDP-MSH), by first defin

226 oximity to the bound ligand [Nle(4),D-Phe(7)]melanocyte-stimulating hormone (NDP-MSH), thereby differ

227 neuropeptide glutamic acid-isoleucine/alpha-melanocyte-stimulating hormone (NEI/alphaMSH) peptides.

228 were carried out to determine the effect of melanocyte-stimulating hormone on tyrosinase gene transc

229 (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptides.

230 grown in the presence of 10-11-10-9 M alpha-melanocyte-stimulating hormone prior to stimulation.

231 gh actions on TRH neurons, addition of alpha-melanocyte-stimulating hormone produced a 3.5-fold incre

232 ultures prepared from 7B2 null mice restored melanocyte-stimulating hormone production, substantiatin

233 the expression of proopiomelanocortin/alpha-melanocyte-stimulating hormone, provoked by C75 and reve

234 Allelic variation at the melanocyte stimulating hormone receptor (MC1R) gene has

235 e mutation in a classical pigmentation gene, melanocyte stimulating hormone receptor (MC1R), is stron

236 e skin, is a high-affinity antagonist of the melanocyte-stimulating hormone receptor (MC1-R), thus ex

237 aberrantly antagonizes the MC4-R, a related melanocyte-stimulating hormone receptor expressed in hyp

238 that modifies coat color by antagonizing the melanocyte-stimulating hormone receptor or MC1-R.

239 d to image melanoma through targeting of the melanocyte-stimulating hormone receptor.

240 alpha-melanocyte--stimulating hormone to the melanocyte-stimulating--hormone receptor (MSHR), the pro

241 ologies concerning cells which express alpha-melanocyte-stimulating hormone receptors and utilize the

242 In contrast, alpha-melanocyte stimulating hormone reduced cell attachment,

243 icotropin-releasing factor, leptin and alpha-melanocyte stimulating hormone regulate cytokine balance

244 These results suggest that alpha-melanocyte-stimulating hormone regulates nitric oxide pr

245 mic explants but significantly reduced alpha melanocyte stimulating hormone release in vitro.

246 ature just before light onset, whereas alpha-melanocyte stimulating hormone release, especially at th

247 ively increases beta-endorphin but not alpha-melanocyte-stimulating hormone release in the hypothalam

248 mediating immunomodulatory actions of alpha-melanocyte-stimulating hormone remains to be seen.

249 y, whereas receptor binding with the agonist melanocyte-stimulating hormone resulted in an increased

250 h the melanocortin analog [Nle, D-Phe]-alpha-melanocyte-stimulating hormone (starting 3 or 6 hrs afte

251 ndothelin 1, hepatocyte growth factor, alpha-melanocyte stimulating hormone, stem cell factor, and fi

252 Neuropeptide Y (NPY) inhibited and alpha-melanocyte-stimulating hormone stimulated ARC glucose-ex

253 rease in tyrosinase mRNA occurred 60 h after melanocyte-stimulating hormone stimulation and was follo

254 tial glands of rodents is regulated by alpha-melanocyte stimulating hormone, the major agonist for me

255 ith the regulation of melanogenesis by alpha-melanocyte-stimulating hormone through melanocortin 1 re

256 e stimulating hormone analogue [Nle4,D-Phe7] melanocyte stimulating hormone to bind or activate the c

257 tern immunoblotting and the ability of alpha-melanocyte stimulating hormone to oppose the actions of

258 We have previously shown alpha-melanocyte stimulating hormone to protect melanocytes an

259 In mice and humans, binding of alpha-melanocyte--stimulating hormone to the melanocyte-stimul

260 of NF-kappaB DNA binding activity with alpha-melanocyte-stimulating hormone was detected 2 h after ce

261 n cAMP in response to stimulation with alpha-melanocyte-stimulating hormone was measured in HEK-293 c

262 vating cyclic adenosine monophosphate, alpha-melanocyte-stimulating hormone was not found to have any

263 appear to be physiological targets of alpha-melanocyte-stimulating hormone, which inhibits food inta

264 d tumorigenicity assays indicates that alpha-melanocyte-stimulating hormone, which is overproduced by

265 onses to the cAMP agonists cholera toxin and melanocyte-stimulating hormone, which normally promote m

266 ch aims to maintain high urine output; alpha-melanocyte-stimulating hormone, with anti-inflammatory a

267 and in a subset of cells coexpressing alpha-melanocyte-stimulating hormone within the pituitary pars